USPTO serial 88776160
ILIAS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 13, 2022
- Examiner
- FALK, ERIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ILIAS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janice Housey
Janice Housey Litmus Law PLLC4 Weems Lane #240Winchester, VA 22601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents and preparations, other than for medical or veterinary use; biologics in the nature of biological preparations for use in cell cultures, other than for medical or veterinary use; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical catalysts; biological preparations for use in industry and science, other than for medical or veterinary purposes; bacterial preparations other than for medical and veterinary use; bacteriological preparations other than for medical and veterinary use; cultures of microorganisms, other than for medical and veterinary use; industrial chemicals; diagnostic preparations, other than for medical or veterinary purposes; biological tissue cultures other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; adjuvants, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Biochemicial drug for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; diagnostic reagents for medical purposes; pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; stem cells for veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; enzyme preparations for medical purposes; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; diagnostic preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical reagents for medical or veterinary purposes; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; genetic identity tests comprised of reagents for medical purposes; biological preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations for veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; bacteriological preparations for medical and veterinary use; biological reagents for clinical medical use; stem cells for medical purposes; drugs for medical purposes featuring drugs for the purpose of treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; medicines for human purposes featuring medicines for the purpose of treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cell therapeutics for medical use | ACTIVE | — |
| 009 | Electric bio-sensors; glassware for laboratory scientific experiments; incubator for laboratory use in cell culture; laboratory equipment, namley, protein sequence analysis equipment being laboratory apparatus; nucleic acid sequencers for scientific purposes for use in analyzing nucleic acide; petri dishes for laboratory use used in cell culture; bioreactor for cell culturing; apparatus for analyzing biochips for laboratory use; laboratory centrifuges; cell culture apparatus for laboratory use, namely, bioreactor for cell culturing; probes for scientific purposes; physical and chemical laboratory apparatus and instruments, namley, apparatus and instruments for cell culturing; particle foreign substances detectors for laboratory use, namely, detectors used in cell culturing; ultrasonic sensors for molecular biology research in the nature of sensors used in cell culturing; bioreactors for laboratory use; microscopes for medical use; laboratory chemical reactors | ACTIVE | — |
| 035 | Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services featuring drugs; retail and wholesale store services featuring veterinary drugs; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring health preparations; retail and wholesale store services featuring medical supplies; retail and wholesale store services featuring preparations for veterinary use; sales promotion for others; marketing services | ACTIVE | — |
| 042 | Research and development of technology for biotechnology in the nature of cell biology; biomedical research services; technological research in the field of cell biology; scientific research; biological research; laboratory research in the field of cell biology; scientific research and development; biological research and analysis; biotechnological research; cell separation research services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; medical research; laboratory research in the field of pharmaceuticals; genetic testing for scientific research purposes; structural and functional analysis of genomes; medical laboratory services; stem cell research services; scientific laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ILIAS Biologics Inc.
- Other trademarks owned by ILIAS Biologics Inc.
- Other trademarks owned by ILIAS Biologics Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ILIAS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 16, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 16, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 16, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Mar 16, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 16, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 16, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 16, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 13, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 13, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 27, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 27, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 7, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 23, 2022 | ADBS | 1(B) BASIS DELETED; NEW BASIS REQUESTED | — |
| Aug 23, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Aug 23, 2022 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Aug 22, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 18, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 16, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 16, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 16, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 27, 2022 | TPAD | TEAS PETITION TO AMEND BASIS RECEIVED | — |
| Feb 18, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 16, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 16, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 16, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 18, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 16, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 16, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 16, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 16, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 18, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 18, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 18, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 18, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 18, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 27, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 27, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 27, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 27, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 27, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 27, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 3, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 31, 2020 | NWAP | NEW APPLICATION ENTERED | — |